Search Results 791-800 of 17457 for PCOS benefits

  1. Efficacy And Safety Of Nintedanib In Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

  2. A Study to Assess Spinopelvic Parameters Based on Radiographic View and Patient Positioning - Mayo Clinic

    The purpose of this study is to evaluate changes in pubic symphysis to sacrococcygeal junction distance (PSCD) between supine and standing anteroposterior (AP) ...

  3. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

  4. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

  5. Resting State Connectivity in Adolescents with Postural Orthostatic Tachycardia Syndrome and Chronic Pain - Mayo Clinic

    About this study. The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia ...

  6. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3) ...

  7. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

  8. Understanding Pulmonary Fibrosis using iPSC Technology - Mayo Clinic

    The purpose of this study is to obtain lung fibroblasts (a cell type that participates in fibrosis of the lung) to study then in the laboratory to identify why ...

  9. Top 5 Social Media Stories — Week of June 14, 2024 - Mayo Clinic News Network

    It's a long-standing discussion for all who want to get into shape. When is the best time to exercise? Morning, midday and evening workouts all have benefits.

  10. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...